About GentaGenta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The research programs of two major platform programs that center on oligonucleotides and small molecules. Anchored Genasense Injection is the Company’s lead compound from its oligonucleotide program disclaimer . The company has a New Drug Application with the Food and Drug Administration for the use of Genasense fludarabine and cyclophosphamide for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia . Genta has a Marketing Authorization Application to the European Medicines Agency concluded for the use of Genasense plus dacarbazine for the treatment of patients with advanced melanoma. The leading drug in small molecule Genta program is Ganite , which visit the Company is exclusively in the U.S. For the treatment of symptomatic patients with cancer hypercalcemia that is resistant to moisture For more information about Genta, please consult our website:.
– the safety and effectiveness of company’s products or product candidates; – the company’s assessment of its clinical trials; – the commencement and completion of clinical trials; – to develop the ability of the Company manufacture, license and sell its products or product candidates; – to give the company’s ability and successfully execute license and collaborative agreements, if any; – the adequacy of the company’s capital resources and cash flow projections and the ability business of the to obtain sufficient financing to maintain the company planned operations;.
The research team, as expected colleagues at the University of Michigan in University of Pennsylvania used to Nuclear Magnetic Resonance Imaging to measure blood flow in the brain during normal reactions quick and slow lapse reactions. The survey was supported by grants of the DSO National Laboratories in Singapore financed, the National Institute of Health, of the nation Institute on Drug Abuse, to the NASA Commercialisation Center, and the Air Force Office of Scientific Research.
####Other study authors are Jiat Chow Tan, Hui J. Zheng , and Sarayu Parimal of the Cognitive Neuroscience Lab at Dukes – NUS Graduate Medical School;. Daniel Weissman from University of Michigan Department of Psychology, David Dinges of the University of Pennsylvania School of Medicine, and Vitaly Zagorodnov of the your computer Engineering Department of the Nanyang Technological University in Singapore.